Active surveillance of metastatic kidney cancer

Active surveillance involves closely watching a patient’s condition but not giving any treatment unless there are changes in test results that show the condition is getting worse. This large real world study conducted at a number of academic and community hospitals describes outcomes for patients with metastatic renal cell carcinoma (RCC) who were undergoing active […]

read more

Active surveillance for young patients with small renal masses

Active surveillance is increasingly being used for the management of small renal masses. However, questions remain regarding the safety and durability of active surveillance in younger patients. Two hundred and twenty four (224) patients aged 60 or younger were included in the study and followed for an average of 4.9 years. 30.4% of these patients […]

read more

Active surveillance is a safe strategy for small renal masses suspected to be cancer

A recent study published at the 21st Annual Meeting of the Society of Urologic Oncology (SUO) concluded that active surveillance is a safe and long lasting management strategy for some patients with small renal masses, which are suspected to be stage T1a (≤4 cm) renal cell carcinoma (RCC). The researchers found the cancer-specific survival rate […]

read more

Triggers for delayed treatment in patients with small renal masses undergoing active surveillance

Active surveillance is an acceptable management strategy for patients with small renal masses. It avoids the risks of surgery, preserves renal function, and delays treatment until it is necessary. However, while the selection of patients to undergo active surveillance is sometimes difficult, all major guidelines and opinion-leaders consider this as an option for patients with […]

read more

Triggers for intervention in patients with small renal masses undergoing active surveillance

Patients with small renal masses are often over diagnosed and over treated. Kidney cancer guidelines recommend active surveillance for some patients; however, this is not often used by clinicians. A reason for this is a lack of agreement on the factors that prompt intervention. This review looks at 1870 patients from 10 studies undergoing active […]

read more

Evidence in favour of active surveillance for small renal masses

Two studies presented at the American Urological Association 2020 Virtual Experience this month provide evidence that active surveillance for small renal masses among older patients is as effective as surgery in terms of survival for patients with suspected renal cell carcinoma (RCC). In a study from Oxford University Hospitals 208 patients with 212 T1a small […]

read more

Psychological distress in patients undergoing active surveillance for small renal masses

Around half of all cases of renal cell carcinoma (RCC) are incidentally diagnosed on imaging as small renal masses, clinical stage T1a and smaller than 4 cm. Around 30% of small renal masses are found to be benign. The management of small renal masses is under debate, including whether a biopsy should be performed for […]

read more

Long-term risk of recurrence after surgery for kidney cancer

A recent study published in the journal European Urology investigated the long-term risk of recurrence in people who had had a nephrectomy for the treatment of localised renal cell carcinoma (RCC) in order to determine the usefulness of long-term follow-up (surveillance). A retrospective analysis of 1943 patients who took part in the ECOG E2805 clinical […]

read more

Universal active surveillance for small renal masses

A study presented at the Society of Urologic Oncology (SUO) in Washington, USA last week concluded that universal initial active surveillance for patients with small renal masses (SRMs) less than 3 cm in diameter using predefined progression criteria can safely delay or avoid treatment for most patients. In the study, active surveillance was recommended for […]

read more

IKCS 2019: Management of small renal masses

In this video interview, Dr Eric Singer from Rutgers Cancer Institute of New Jersey, USA discusses the management of small renal masses at the International Kidney Cancer Symposium (IKCS) in Miami earlier this month. Watch the video interview on Oncology Tube here

read more
Showing 1 to 10 of 18 results
  TOP